Page 16 - Roots Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gene Therapies Market Driven by the potential treat the root cause of diseases, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiat...

Over 100 CMOs presently claim to offer manufacturing services for antibodies The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial). More than 90% service providers are focused on the production of monoclonal antibodies However, players based in Asia are now increasingly focusing on the development of ...